StonvexLoading…
StonvexStonvexStonvexCore line items from MNTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.11M | $2.11M | $3.09M | $299.00K |
Operating Income | $-27.25M | $-29.68M | $-68.17M | $-91.28M |
Net Income | $-30.47M | $-34.95M | $-68.92M | $-95.44M |
EPS (Diluted) | $-49.10 | $-414.01 | $-323.96 | $-58.53 |
Total Assets | $40.32M | $9.95M | $20.65M | $92.42M |
Total Liabilities | $23.18M | $17.76M | $17.46M | $53.82M |
Cash & Equivalents | $12.81M | $1.57M | $2.12M | $61.09M |
Free Cash Flow OCF − CapEx | $-23.29M | $-16.61M | $-61.92M | $-88.47M |
Shares Outstanding | 622.94K | 84.41K | 212.74K | 84.44M |